The Journal of Musculoskeletal Medicine Vol 27 No 6

The primary care physician's guide to inflammatory arthritis: Diagnosis

June 02, 2010

Inflammatory arthritis includes a variety of diseases; the most common are rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. A large proportion of patients seen in most rheumatology practices have inflammatory arthritis; these patients also are seen in the primary care setting, where they present initially before a diagnosis has been made. The inflammatory arthritides are chronic progressive diseases that can cause irreversible joint damage even early in the disease course.

Inflammatory bone loss in joint replacements: The mechanisms

June 01, 2010

More than 1 million total joint arthroplasties (TJAs) are performed in the United States each year, and much higher demand is projected. Most TJAs are successful, but aseptic loosening of implants remains a problem that limits long-term success. Aseptic osteolysis, an inflammatory reaction, occurs in up to 10% of patients at 10 years postsurgery.

A case of arthritis, pulmonary nodules, and hilar adenopathy

June 01, 2010

After a trip to El Salvador, a woman experienced fever, malaise, and other symptoms. She had a history of a positive antinuclear antibodies test result, Raynaud phenomenon, and erythematous rash. The patient was hospitalized for pneumonia, and her symptoms persisted when she received antibiotics. Later her right ankle became red, swollen, and tender. Examination of the patient's extremities showed osteoarthritis changes.

Physical activity plan recommends new “vital sign”

May 30, 2010

Health care professionals should make physical activity a vital sign that they assess and discuss with their patients as part of the recently announced National Physical Activity Plan, according to the American College of Sports Medicine (ACSM)

Lupus Initiative to Increase Awareness and Understanding

May 30, 2010

An educational initiative aimed at eliminating ethnic and racial disparities in the diagnosis and management of lupus was launched recently by the American College of Rheumatology (ACR) in conjunction with the US Department of Health and Human Services' Office of Minority Health, Office on Women’s Health, and Office of the Surgeon General.

A Man With 10 Years of Exquisite Finger Pain

May 29, 2010

A 25-year-old man was seen in the orthopedic clinic with a complaint of severe, exquisite pain at the ulnar aspect of the distal phalanx of his dominant right index finger. The pain had been present for 10 years, but he had not sought treatment.

Taping ankles protects knees in sports activities

May 28, 2010

Ankle taping not only increases mechanical stability at the ankle joint during the performance of open sports tasks (in an unpredictable situation) but also provides protective benefits to the knee, according to researchers at Fremantle Hospital; the University of Western Australia; and other centers in Fremantle, Western Australia. Taping helps ankle stability by limiting motion and protects the knee by reducing internal rotation moments and varus impulses during both planned and unplanned maneuvers.

Quick steps to reducing obesity and knee osteoarthritis

May 28, 2010

Walking with short, quick steps results in a small but significant increase in metabolic cost that may be beneficial for weight reduction or maintenance in obese persons and reduce the risk of knee osteoarthritis (OA), according to researchers at the Biomechanics and Energy Metabolism Laboratories, University of Massachusetts Amherst

Some jobs may be a pain in the knee, or hip

May 27, 2010

Several occupational tasks are associated with symptomatic lower extremity osteoarthritis (OA). A variety of physically demanding tasks are associated with increased odds for knee OA andhip OA, and there is a particularly strong association with lifting tasks.

Early RA core set measures may predict later joint destruction

May 27, 2010

In patients who have early rheumatoid arthritis (RA), American College of Rheumatology (ACR) core set measures after 12 weeks of nonbiologic disease-modifying antirheumatic drug (DMARD) treatment may predict the progression of articular destruction 2 years later.